BDBM260158 US9522910, Table 1 Compound 7: 3-{2-[2-methyl-5-({4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}carbamoyl)phenyl]ethynyl}indazole-6-carboxylic acid
SMILES CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cn3cnc4cc(ccc34)C(O)=O)cc2C(F)(F)F)CC1
InChI Key InChIKey=GBTVZRONPVRLHC-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 260158
TargetTyrosine-protein kinase ABL1 [T315I](Homo sapiens (Human))
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Affinity DataIC50: <20nMAssay Description:Kinase activity and inhibition was measured by established protocols (see e.g. Braunwalder et al., A Solid-Phase Assay for the Determination of Prote...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Affinity DataIC50: <20nMAssay Description:Kinase activity and inhibition was measured by established protocols (see e.g. Braunwalder et al., A Solid-Phase Assay for the Determination of Prote...More data for this Ligand-Target Pair